Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | CES2 | O00748 | 4/20 | 0.65 |
| ▸ | CES1 | P23141 | 4/20 | 0.65 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.62 |
| ▸ | PPARG | P37231 | 7/20 | 0.62 |
| ▸ | PPARD | Q03181 | 7/20 | 0.62 |
| ▸ | PPARA | Q07869 | 7/20 | 0.62 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.62 |
| ▸ | TSHR | P16473 | 5/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TLR2 | O60603 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | FABP4 | P15090 | 2/20 | 0.62 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.62 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3405859 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL5708548 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL963631 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044627 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL5945790 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044676 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044655 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044682 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL21044632 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL8446000 | 1.00 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3507280-A2 | COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES | PTT Global Chemical Public Company Limited (TH) | 2019-07-10 | — | — | EP | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| CN-120172821-B | Alkynol compound, preparation thereof and application thereof in addition type liquid silicone rubber | 广东盛唐新材料技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20250205362-A1 | LIPID NANOPARTICLES | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-3810722-B1 | 3D PRINTING BUILD MATERIALS AND SUPPORT MATERIALS COMPRISING A PHOSPHOR | 3D SYSTEMS INC (US) | 2025-04-02 | — | — | EP | disclosed |
| EP-4530325-A2 | 3D PRINTING BUILD MATERIALS AND SUPPORT MATERIALS COMPRISING A PHOSPHOR | 3D Systems, Incorporated (US) | 2025-04-02 | — | — | EP | disclosed |
| CN-119698302-A | Lipid nanoparticles | 国立大学法人北海道大学 | 2025-03-25 | — | — | CN | disclosed |
| EP-4501359-A1 | LIPID NANOPARTICLES | National University Corporation Hokkaido University (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20250019544-A1 | WATER DISPERSIBLE SUPPORT MATERIALS FOR 3D PRINTING | 3D SYSTEMS INC (US) | 2025-01-16 | — | — | US | disclosed |
| US-12129380-B2 | Water dispersible support materials for 3D printing | 3D SYSTEMS, INC. (US) | 2024-10-29 | — | — | US | disclosed |
| US-20060030518-A1 | Acylated insulin | SCIAPS, INC. | 2006-02-09 | — | — | US | disclosed |
| US-6514298-B2 | A imine group containing fuel additive having a superior detergent effect to conventional gasoline detergents and excellent detergency of the injection nozzles of a diesel engine and is free of being sludge | NIPPON MITSUBISHI OIL CORPORATION (JP) | 2003-02-04 | — | — | US | disclosed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | disclosed |
| EP-1132454-A1 | Fuel additive and fuel composition | Nippon Mitsubishi Oil Corporation (JP) | 2001-09-12 | — | — | EP | disclosed |
| US-20010005957-A1 | Fuel additive and fuel composition | NIPPON MITSUBISHI OIL CORPORATION | 2001-07-05 | — | — | US | disclosed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
| US-3976697-A | Preparation of tertiary amines | TEXACO INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3975373-A | CYCLOPENTANONE HELVETICOSIDE | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-08-17 | — | — | US | disclosed |
| US-3951946-A | Cardioglycoside derivatives of the strophanthidin type, a process for their manufacture and medicinal preparations containing these compounds | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205362-A1 | LIPID NANOPARTICLES | ECH1, C1R, SGMS1 | KMT2A 3104/4885MAPT 3784/4885CES2 128/4885 |
| US-20010005957-A1 | Fuel additive and fuel composition | NOTUM, DEGS1, NDUFC1 | KMT2A 4225/4885MAPT 4066/4885CES2 211/4885 |
| US-20060030518-A1 | Acylated insulin | INSR, BCAT1, SLC1A5 | KMT2A 2109/4885MAPT 4326/4885CES2 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.